These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
175 related articles for article (PubMed ID: 24399680)
1. A new high-sensitive nephelometric method for assaying serum C-reactive protein based on phosphocholine interaction. Drieghe SA; Alsaadi H; Tugirimana PL; Delanghe JR Clin Chem Lab Med; 2014 Jun; 52(6):861-7. PubMed ID: 24399680 [TBL] [Abstract][Full Text] [Related]
2. A new turbidimetric method for assaying serum C-reactive protein based on phosphocholine interaction. Tugirimana PL; Holderbeke AL; Kint JA; Delanghe JR Clin Chem Lab Med; 2009; 47(11):1417-22. PubMed ID: 19778286 [TBL] [Abstract][Full Text] [Related]
3. Evaluation of an improved immunoturbidimetic assay for serum C-reactive protein on a COBAS INTEGRA 400 Analyzer. Sánchez A; Mirabel JL; Barrenechea E; Eugui J; Puelles A; Castañeda A Clin Lab; 2002; 48(5-6):313-7. PubMed ID: 12071582 [TBL] [Abstract][Full Text] [Related]
4. A functional turbidimetric method to determine C-reactive protein in horses. Tugirimana PL; De Clercq D; Holderbeke AL; Kint JA; De Cooman L; Deprez P; Delanghe JR J Vet Diagn Invest; 2011 Mar; 23(2):308-11. PubMed ID: 21398452 [TBL] [Abstract][Full Text] [Related]
5. Comparison of high-sensitivity C-reactive protein serum assay results obtained using Dade-Behring BNII nephelometer and Ortho Vitros FS 5.1 clinical analyzer in respect of CRP-related risk assessment of chronic metabolic diseases. Kusnierz-Cabala B; Gernand W; Zabek-Adamska A; Tokarz A; Naskalski JW Clin Lab; 2008; 54(9-10):341-6. PubMed ID: 19097491 [TBL] [Abstract][Full Text] [Related]
6. [Evaluation of analytical measurement ranges of three full range C-reactive protein tests using immunoturbidimetric assay]. Lee YJ; Kim JM; Park DS Korean J Lab Med; 2010 Feb; 30(1):9-16. PubMed ID: 20197716 [TBL] [Abstract][Full Text] [Related]
7. Analytical evaluation of particle-enhanced immunonephelometric assays for C-reactive protein, serum amyloid A and mannose-binding protein in human serum. Ledue TB; Weiner DL; Sipe JD; Poulin SE; Collins MF; Rifai N Ann Clin Biochem; 1998 Nov; 35 ( Pt 6)():745-53. PubMed ID: 9838988 [TBL] [Abstract][Full Text] [Related]
9. Reference interval for serum C-reactive protein in healthy blood donors using the Dade Behring N Latex CRP mono assay. Erlandsen EJ; Randers E Scand J Clin Lab Invest; 2000 Feb; 60(1):37-43. PubMed ID: 10757452 [TBL] [Abstract][Full Text] [Related]
10. Immunoturbidimetric determination of C-reactive protein (CRP) and high-sensitivity CRP on heparin plasma. Comparison with serum determination. Dupuy AM; Badiou S; Descomps B; Cristol JP Clin Chem Lab Med; 2003 Jul; 41(7):948-9. PubMed ID: 12940523 [TBL] [Abstract][Full Text] [Related]
11. Evaluation of a species-specific C-reactive protein assay for the dog on the ABX Pentra 400 clinical chemistry analyzer. Hindenberg S; Klenner-Gastreich S; Kneier N; Zielinsky S; Gommeren K; Bauer N; Moritz A BMC Vet Res; 2017 May; 13(1):146. PubMed ID: 28558755 [TBL] [Abstract][Full Text] [Related]
12. Evaluation of the high-sensitivity, full-range Olympus CRP OSR6199 application on the Olympus AU640. Marie Dupuy A; Boutet A; Paul Cristol J Clin Chem Lab Med; 2007; 45(3):402-6. PubMed ID: 17378741 [TBL] [Abstract][Full Text] [Related]
13. Evaluation of a sensitive immunoluminometric assay for the determination of C-reactive protein (CRP) in serum and plasma and the establishment of reference ranges for different groups of subjects. Wood WG; Lüdemann J; Mitusch R; Heinrich J; Maass R; Frick U Clin Lab; 2000; 46(3-4):131-40. PubMed ID: 10791120 [TBL] [Abstract][Full Text] [Related]
14. Analytical performance of the Synchron LX20 Pro, BN trade mark II and IMMAGE high sensitivity C-reactive protein assays and concordance in cardiovascular risk stratification. McWhorter VC; Ford LC; Butch AW Clin Chim Acta; 2004 Sep; 347(1-2):71-9. PubMed ID: 15313143 [TBL] [Abstract][Full Text] [Related]
15. Analytical performance and clinical efficacy for cardiovascular risk estimation of an Olympus immunoturbidimetric high-sensitivity C-reactive protein assay. Jovicić S; Ignjatović S; Dajak M; Majkić-Singh N Clin Chem Lab Med; 2006; 44(2):228-31. PubMed ID: 16475913 [TBL] [Abstract][Full Text] [Related]
16. Evaluation of fluorescence hs-CRP immunoassay for point-of-care testing. Oh SW; Moon JD; Park SY; Jang HJ; Kim JH; Nahm KB; Choi EY Clin Chim Acta; 2005 Jun; 356(1-2):172-7. PubMed ID: 15936314 [TBL] [Abstract][Full Text] [Related]
17. A new method of measuring C-reactive protein, with a low limit of detection, suitable for risk assessment of coronary heart disease. Eda S; Kaufmann J; Molwitz M; Vorberg E Scand J Clin Lab Invest Suppl; 1999; 230():32-5. PubMed ID: 10389199 [TBL] [Abstract][Full Text] [Related]
18. [Clinical value of nephelometric assay of C-reactive protein]. Audhuy B; Aby MA; Attali P; Pinget M; Dorner M Sem Hop; 1983 Jan; 59(1):49-52. PubMed ID: 6297088 [TBL] [Abstract][Full Text] [Related]
19. Verification of the analytical range of a new reagent for full-range C-reactive protein determination. Piéroni L; Chahbani N; Hainque B Clin Chem Lab Med; 2009; 47(1):109-11. PubMed ID: 19055474 [TBL] [Abstract][Full Text] [Related]